Novo Nordisk
In the news
The first generic weight loss drug hit SA in August — with many expected to follow. Will it be enough to kill the black market?
As patents expire, generic versions of blockbuster weight-loss and diabetes drugs like Ozempic arrive in South Africa. But will price drops be enough to end the dangerous black…
As it rages, the semaglutide debate exposes public trust deficit in healthcare
The contentious debate around semaglutide in South African healthcare extends beyond its use for obesity and type 2 diabetes, exposing deep-seated issues of access,…
Regulators tighten noose on recalled GLP-1 medicines
South Africa's health regulators have warned doctors, pharmacists, and other healthcare professionals that they face disciplinary action for continuing to prescribe or dispense…